Drug Accessibility

Aurobindo Pharma USA, Inc. a wholly owned subsidiary of the Company, today announced that it has received approval from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC (“Lannett”). The transaction, valued at $250 million on a cash-free, debt-free basis and inclusive of normalized working capital, is expected to …